I've been following the research about uric acid and it's potentially protective role in MS for a couple of years now. The inosine trial you are referring should have started in 2002 and was to be ended in december 2004. Yet it is recruiting patients according to the website...Weird.
I am just as curious as you are.
HappyDaddy, I guess you are maybe familiar with the other Inosine trial, but I mention it for the sake of other interested readers:
Youguslavian researchers have already completed an inosine trial with 32 patients lasting for two years. The results were presented, but not in detail, at the 2004 AAN meeting in May. I've only read the poster abstract of that presentation, but out of the 32 patients, 6 had signs of MS activity during the treatment period. However, all patients who detoriated continued to show declining uric acid levels, while those who were stable or even improved clinically, had raised serum uric acid levels. The work of this team will hopefully be published during 2005.